Treatment of upper limb deep vein thrombosis with low molecular weight heparin

被引:2
作者
Shah, MK [1 ]
Black-Schaffer, RM [1 ]
机构
[1] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA
关键词
upper extremity; deep vein thrombosis; treatment; low molecular weight heparin;
D O I
10.1097/01.PHM.0000064740.19570.2A
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Upper limb deep vein thrombosis has been an under-recognized disease; however, physicians' awareness of it as a cause of arm pain and edema is increasing. Previously thought of as benign, upper limb deep vein thrombosis has been shown in recent studies to pose a significant risk for pulmonary embolus and death. The need for treatment is now recognized; however, effective treatments for upper limb deep vein thrombosis have not been fully defined. Anticoagulation with oral agents is known to be successful in preventing complications and recurrence. This report presents the first case of upper limb deep vein thrombosis successfully treated with only low molecular weight heparin.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [31] Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy
    Tousovska, Katerina
    Zapletal, Ondrej
    Skotakova, Jarmila
    Bukac, Josef
    Sterba, Jaroslav
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (07) : 583 - 589
  • [32] Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin
    Lindhoff-Last, E
    Nakov, R
    Misselwitz, F
    Breddin, HK
    Bauersachs, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1137 - 1142
  • [33] The Clinical Efficacy of Maizhiling Combined with Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis after Spinal Cord Injury
    Ma, Xuefang
    Liu, Xiaofeng
    Wang, Gaowei
    Xia, Xiang
    Yi, Xiaobo
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 83 : 124 - 129
  • [34] Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery
    De, Anushtup
    Roy, Prabal
    Garg, Vinod K.
    Pandey, Narendra K.
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 57 - 61
  • [35] Outpatient therapy with low-molecular-weight heparins:: New perspectives for treatment of deep vein thrombosis
    Büller, HR
    HAEMOSTASIS, 1998, 28 : 91 - 94
  • [36] Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (04) : 225 - 239
  • [37] DOSE ADJUSTED HEPARIN TREATMENT OF DEEP VENOUS THROMBOSIS - A COMPARISON OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
    HANDELAND, GF
    ABILDGAARD, U
    HOLM, HA
    ARNESEN, KE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) : 107 - 112
  • [38] Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
    Lee, Joon Kyu
    Lee, Kee Byoung
    Kim, Joong Il
    Park, Gun Tae
    Cho, Young Chang
    KNEE SURGERY & RELATED RESEARCH, 2021, 33 (01)
  • [39] Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
    Joon Kyu Lee
    Kee Byoung Lee
    Joong Il Kim
    Gun Tae Park
    Young Chang Cho
    Knee Surgery & Related Research, 33
  • [40] Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
    Han, Ji Min
    Koh, Youngil
    Kim, Sung Hwan
    Suh, Sung Yun
    Cho, Yoon Sook
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Gwak, Hye Sun
    MEDICINA-LITHUANIA, 2023, 59 (02):